It is estimated one in 100 people taking semaglutide will experience pancreatitis according to safety information distributed with the drug
Nature 414:105111
Consulte con su mdico si no observa mejoras despus de 3-6 meses, experimenta efectos secundarios graves (dolor abdominal intenso, nuseas severas, signos de deshidratacin) o tiene antecedentes de carcinoma medular de tiroides
As the GLP1 boom pushes consumers toward more protein and better nutrition, fast food chains are adapting their menus
Other things people notice include fatigue, dizziness, injection site reactions, and a noticeably reduced appetite, even for things like alcohol
Richards J, Bang N, Ratliff EL, et al